Nahom Worku Teshager
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nahom Worku Teshager has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Amare Wondim
Department of Pediatrics and Child Health Nursing, School of Nursing, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
1 shared publication - Anteneh Ayelign Kibret
School of Psychology and Public Health, La Trobe University, Bundoora, Australia
1 shared publication Asefa Adimasu Taddese
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
1 shared publication- Asefa Adimasu Taddese
Department of Epidemiology and Biostatistics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
1 shared publication Ashenafi Tazebew Amare
Department of Pediatrics and Child Health, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia
1 shared publication- Ashenafi Tazebew Amare
Ethiopian Blood and Tissue Bank Service, Addis Ababa, Ethiopia
1 shared publication
Latest Publications
- Open Access
- 26 November 2025
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 15 (1)
Development and Validation of a Diagnostic Prediction Model for Neonatal Sepsis in a Low-Resource Setting, Ethiopia
Background Neonatal sepsis remains a major cause of preventable neonatal mortality globally, yet diagnosis remains difficult in low-resource settings due to the inaccessibility and the long turnaround time of blood culture. Clinical prediction models can support the early detection and management of sepsis. Objective To develop and internally validate a diagnostic prediction model for the diagnosis of neonatal sepsis in a low-resource setting, Ethiopia. Methods An institution-based cross-sectional study was conducted from January 2022 to December 2024. We collected data through medical record review among 607 newborns with suspected sepsis. Predictors were selected using the least absolute shrinkage and selection operator (LASSO) and then subjected to multivariable logistic regression. Model performance was assessed by discrimination and calibration. Ten-fold cross-validation was performed to assess the model’s internal validity, and clinical utility was assessed by decision curve analysis. External validation was not performed. The R statistical software was used for data analysis. Results The proportion of sepsis was 36.1% (95% CI: 32.3, 39.9). The final model incorporated maternal anemia, fever, antibiotic use during pregnancy, temperature abnormality, presence of a focus of infection, invasive procedure before admission, leukocytosis, leukopenia, and thrombocytopenia. The model demonstrated an area under the receiver operating characteristic curve (AUROC) of 0.87(95% CI: 0.84, 0.90) and good calibration. The model achieved a sensitivity of 86.8%, specificity of 71.1%, negative predictive value of 90.5%, and a positive likelihood ratio of 3.0. The decision curve analysis showed a higher net benefit than the “treat-all” or “treat-none” strategies. Conclusions We developed a diagnostic prediction model for neonatal sepsis, demonstrating good discrimination, high sensitivity, and negative predictive value, with a modest positive likelihood ratio, reflecting its utility for ruling in or out sepsis. The model can be incorporated into routine neonatal care practices and quality improvement initiatives following external validation.
- 26 November 2025
- Published by Springer Nature in Journal of Epidemiology and Global Health
- Vol. 15 (1)
Open AccessDevelopment and Validation of a Diagnostic Prediction Model for Neonatal Sepsis in a Low-Resource Setting, Ethiopia
Background Neonatal sepsis remains a major cause of preventable neonatal mortality globally, yet diagnosis remains difficult in low-resource settings due to the inaccessibility and the long turnaround time of blood culture. Clinical prediction models can support the early detection and management of sepsis. Objective To develop and internally validate a diagnostic prediction model for the diagnosis of neonatal sepsis in a low-resource setting, Ethiopia. Methods An institution-based cross-sectional study was conducted from January 2022 to December 2024. We collected data through medical record review among 607 newborns with suspected sepsis. Predictors were selected using the least absolute shrinkage and selection operator (LASSO) and then subjected to multivariable logistic regression. Model performance was assessed by discrimination and calibration. Ten-fold cross-validation was performed to assess the model’s internal validity, and clinical utility was assessed by decision curve analysis. External validation was not performed. The R statistical software was used for data analysis. Results The proportion of sepsis was 36.1% (95% CI: 32.3, 39.9). The final model incorporated maternal anemia, fever, antibiotic use during pregnancy, temperature abnormality, presence of a focus of infection, invasive procedure before admission, leukocytosis, leukopenia, and thrombocytopenia. The model demonstrated an area under the receiver operating characteristic curve (AUROC) of 0.87(95% CI: 0.84, 0.90) and good calibration. The model achieved a sensitivity of 86.8%, specificity of 71.1%, negative predictive value of 90.5%, and a positive likelihood ratio of 3.0. The decision curve analysis showed a higher net benefit than the “treat-all” or “treat-none” strategies. Conclusions We developed a diagnostic prediction model for neonatal sepsis, demonstrating good discrimination, high sensitivity, and negative predictive value, with a modest positive likelihood ratio, reflecting its utility for ruling in or out sepsis. The model can be incorporated into routine neonatal care practices and quality improvement initiatives following external validation.
- Open Access
- 23 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0286233
Traditional herbal medicine use doubled the risk of multi-organ dysfunction syndrome in children: A prospective cohort study
Background: Traditional herbal medicine (THM) is frequently used in pediatric populations in many low-income countries as a form of healthcare and has been associated with a range of adverse events, including liver toxicity, renal failure, and allergic reactions. Despite these concerns, its impact on multi-organ dysfunction syndrome (MODS) risk has not been thoroughly investigated. Objective: This study aimed to investigate the incidence and predictors of MODS in a pediatric intensive care unit (PICU) in Ethiopia, with a focus on the association between THM use and the risk of MODS. Methods: This was a single-center prospective cohort study conducted at a PICU in the university of Gondar Comprehensive Specialized hospital, Northwest Ethiopia. The study enrolled eligible patients aged one month to 18 years admitted to the PICU during the study period. Data on demographic characteristics, medical history, clinical and laboratory data, and outcome measures using standard case record forms, physical examination, and patient document reviews. The predictors of MODS were assessed using Cox proportional hazards models, with a focus on the association between traditional herbal medicine use and the risk of MODS. Results: A total of 310 patients were included in the final analysis, with a median age of 48 months and a male-to-female ratio of 1.5:1. The proportion and incidence of MODS were 30.96% (95% CI:25.8, 36.6) and 7.71(95% CI: 6.10, 9.40) per 100-person-day observation respectively. Renal failure (17.74%), neurologic failure (15.16%), and heart failure (14.52%) were the leading organ failures identified. Nearly one-third of patients (32.9%) died in the PICU, of which 59.8% had MODS. The rate of mortality was higher in patients with MODS than in those without. The Cox proportional hazards model identified renal disease (AHR = 6.32 (95%CI: 3.17,12.61)), intake of traditional herbal medication (AHR = 2.45, 95% CI:1.29,4.65), modified Pediatric Index of Mortality 2 (mPIM 2) score (AHR = 1.54 (95% CI: 1.38,1.71), and critical illness diagnoses (AHR = 2.68 (95% CI: 1.77,4.07)) as predictors of MODS. Conclusion: The incidence of MODS was high. Renal disease, THM use, mPIM 2 scores, and critical illness diagnoses were independent predictors of MODS. A more than twofold increase in the risk of MODS was seen in patients who used TMH. Healthcare providers should be aware of risks associated with THM, and educate caregivers about the potential harms of these products. Future studies with larger sample sizes and more comprehensive outcome measures are needed.
- 23 February 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19 (2) , e0286233
Open AccessTraditional herbal medicine use doubled the risk of multi-organ dysfunction syndrome in children: A prospective cohort study
Background: Traditional herbal medicine (THM) is frequently used in pediatric populations in many low-income countries as a form of healthcare and has been associated with a range of adverse events, including liver toxicity, renal failure, and allergic reactions. Despite these concerns, its impact on multi-organ dysfunction syndrome (MODS) risk has not been thoroughly investigated. Objective: This study aimed to investigate the incidence and predictors of MODS in a pediatric intensive care unit (PICU) in Ethiopia, with a focus on the association between THM use and the risk of MODS. Methods: This was a single-center prospective cohort study conducted at a PICU in the university of Gondar Comprehensive Specialized hospital, Northwest Ethiopia. The study enrolled eligible patients aged one month to 18 years admitted to the PICU during the study period. Data on demographic characteristics, medical history, clinical and laboratory data, and outcome measures using standard case record forms, physical examination, and patient document reviews. The predictors of MODS were assessed using Cox proportional hazards models, with a focus on the association between traditional herbal medicine use and the risk of MODS. Results: A total of 310 patients were included in the final analysis, with a median age of 48 months and a male-to-female ratio of 1.5:1. The proportion and incidence of MODS were 30.96% (95% CI:25.8, 36.6) and 7.71(95% CI: 6.10, 9.40) per 100-person-day observation respectively. Renal failure (17.74%), neurologic failure (15.16%), and heart failure (14.52%) were the leading organ failures identified. Nearly one-third of patients (32.9%) died in the PICU, of which 59.8% had MODS. The rate of mortality was higher in patients with MODS than in those without. The Cox proportional hazards model identified renal disease (AHR = 6.32 (95%CI: 3.17,12.61)), intake of traditional herbal medication (AHR = 2.45, 95% CI:1.29,4.65), modified Pediatric Index of Mortality 2 (mPIM 2) score (AHR = 1.54 (95% CI: 1.38,1.71), and critical illness diagnoses (AHR = 2.68 (95% CI: 1.77,4.07)) as predictors of MODS. Conclusion: The incidence of MODS was high. Renal disease, THM use, mPIM 2 scores, and critical illness diagnoses were independent predictors of MODS. A more than twofold increase in the risk of MODS was seen in patients who used TMH. Healthcare providers should be aware of risks associated with THM, and educate caregivers about the potential harms of these products. Future studies with larger sample sizes and more comprehensive outcome measures are needed.
- Open Access
Traditional Herbal Medicine Use Tripled the Risk of Multi-organ Dysfunction Syndrome in a Pediatric Intensive Care Unit in Ethiopia: A Prospective Cohort Study
Objective This study aimed to investigate the incidence and predictors of MODS in a Pediatric Intensive Care Unit in Ethiopia, with a focus on the association between traditional herbal medicine (THM) use and the risk of MODS. Methods This was a single-center prospective cohort study conducted at a PICU in Ethiopia. The study enrolled eligible patients aged one month to 18 years admitted to the PICU during the study period. Recruitment was made at the time of admission to the PICU. Data on demographic characteristics, medical history, clinical and laboratory data, and outcome measures using standard case record forms, physical examination, and patient document reviews. The predictors of MODS were assessed using Cox proportional hazards models, with a focus on the association between traditional herbal medicine use and the risk of MODS. Results A total of 310 patients were included in the final analysis, with a median age of 48 months and a male-to-female ratio of 1.5:1. The proportion and incidence of MODS were 30.96% (95% CI:25.8, 36.6) and 7.71(95% CI: 6.10, 9.40) per 100-person-day observation respectively. Renal failure (17.74%), neurologic failure (15.16%), and heart failure (14.52%) were the leading organ failures identified. Nearly one-third of patients (32.9%) died in the PICU, of which 59.8% had MODS. The rate of mortality was higher in patients with MODS than in those without. The Cox proportional hazards model identified renal disease (AHR=6.32 (95%CI: 3.17,12.61)), intake of traditional herbal medication (AHR=2.45, 95% CI:1.29,4.65), modified Pediatric Index of Mortality 2 (mPIM 2) score (AHR=1.54 (95% CI: 1.38,1.71), and critical illness diagnoses (AHR=2.68 (95% CI: 1.77,4.07)) as predictors of MODS. Patients who used THM had a threefold increased risk of MODS (AHR) of 2.45 (95% CI: 1.29, 4.65). Conclusion The incidence of MODS was high. Renal disease, THM use, mPIM 2 scores, and critical illness diagnoses were independent predictors of MODS. A threefold increase in the risk of MODS was seen in patients who used TMH. Healthcare providers should be aware of risks associated with THM, and educate caregivers about the potential harms of these products. Future studies with larger sample sizes and more comprehensive outcome measures are needed.
Open AccessTraditional Herbal Medicine Use Tripled the Risk of Multi-organ Dysfunction Syndrome in a Pediatric Intensive Care Unit in Ethiopia: A Prospective Cohort Study
Objective This study aimed to investigate the incidence and predictors of MODS in a Pediatric Intensive Care Unit in Ethiopia, with a focus on the association between traditional herbal medicine (THM) use and the risk of MODS. Methods This was a single-center prospective cohort study conducted at a PICU in Ethiopia. The study enrolled eligible patients aged one month to 18 years admitted to the PICU during the study period. Recruitment was made at the time of admission to the PICU. Data on demographic characteristics, medical history, clinical and laboratory data, and outcome measures using standard case record forms, physical examination, and patient document reviews. The predictors of MODS were assessed using Cox proportional hazards models, with a focus on the association between traditional herbal medicine use and the risk of MODS. Results A total of 310 patients were included in the final analysis, with a median age of 48 months and a male-to-female ratio of 1.5:1. The proportion and incidence of MODS were 30.96% (95% CI:25.8, 36.6) and 7.71(95% CI: 6.10, 9.40) per 100-person-day observation respectively. Renal failure (17.74%), neurologic failure (15.16%), and heart failure (14.52%) were the leading organ failures identified. Nearly one-third of patients (32.9%) died in the PICU, of which 59.8% had MODS. The rate of mortality was higher in patients with MODS than in those without. The Cox proportional hazards model identified renal disease (AHR=6.32 (95%CI: 3.17,12.61)), intake of traditional herbal medication (AHR=2.45, 95% CI:1.29,4.65), modified Pediatric Index of Mortality 2 (mPIM 2) score (AHR=1.54 (95% CI: 1.38,1.71), and critical illness diagnoses (AHR=2.68 (95% CI: 1.77,4.07)) as predictors of MODS. Patients who used THM had a threefold increased risk of MODS (AHR) of 2.45 (95% CI: 1.29, 4.65). Conclusion The incidence of MODS was high. Renal disease, THM use, mPIM 2 scores, and critical illness diagnoses were independent predictors of MODS. A threefold increase in the risk of MODS was seen in patients who used TMH. Healthcare providers should be aware of risks associated with THM, and educate caregivers about the potential harms of these products. Future studies with larger sample sizes and more comprehensive outcome measures are needed.
- Open Access
- 17 November 2022
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 18
Velamentous cord insertion at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
- 17 November 2022
- Published by Elsevier in Clinical Epidemiology and Global Health
- Vol. 18
Open AccessVelamentous cord insertion at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia
- Open Access
- 23 June 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-9
Mapping BCG vaccination coverage in Ethiopia between 2000 and 2019
Introduction: The Bacille-Calmette–Guerin (BCG) vaccination remains the primary strategy to prevent severe disseminated TB in young children, particularly in high TB-burden countries such as Ethiopia. Accurate knowledge of vaccination coverage in small geographical areas is critically important to developing targeted immunization campaigns. Thus, this study aimed to investigate the spatiotemporal distributions and ecological level determinants of BCG vaccination coverage in Ethiopia. Method: Bacille-Calmette–Guerin immunization coverage and geographical information data were obtained from five different Demographic and Health Surveys, conducted in Ethiopia between 2000 and 2019. Data for independent variables were obtained from publicly available sources. Bayesian geostatistical models were used to predict the spatial distribution of BCG vaccination coverage in Ethiopia. Result: The overall national BCG vaccination coverage between 2000 and 2019 was 65.5%. The BCG vaccine coverage was 53.5% in 2000, 56.9% in 2005, 64.4% in 2011, 79.6% in 2016, and 79.0% in 2019. BCG vaccination coverage increased by 47.6% in Ethiopia from 2000 to 2019, but substantial geographical inequalities in BCG coverage remained at sub-national and local levels. High vaccination coverage was observed in northern, western, and central parts of Ethiopia. Climatic and demographic factors such as temperature, altitude, and population density were positively associated with BCG vaccination coverage. Whereas, healthcare access factors such as distance to health facilities and travel time to the nearest cities were negatively associated with BCG vaccine coverage in Ethiopia. Conclusion: Despite substantial progress in national BCG vaccination coverage, marked spatial variation in BCG coverage persists throughout the country at sub-national and local levels. Healthcare access and climatic and demographic factors determined the spatial distribution of BCG vaccination coverage. Maintaining a high level of vaccination coverage across geographical areas is important to prevent TB in Ethiopia.
- 23 June 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-9
Open AccessMapping BCG vaccination coverage in Ethiopia between 2000 and 2019
Introduction: The Bacille-Calmette–Guerin (BCG) vaccination remains the primary strategy to prevent severe disseminated TB in young children, particularly in high TB-burden countries such as Ethiopia. Accurate knowledge of vaccination coverage in small geographical areas is critically important to developing targeted immunization campaigns. Thus, this study aimed to investigate the spatiotemporal distributions and ecological level determinants of BCG vaccination coverage in Ethiopia. Method: Bacille-Calmette–Guerin immunization coverage and geographical information data were obtained from five different Demographic and Health Surveys, conducted in Ethiopia between 2000 and 2019. Data for independent variables were obtained from publicly available sources. Bayesian geostatistical models were used to predict the spatial distribution of BCG vaccination coverage in Ethiopia. Result: The overall national BCG vaccination coverage between 2000 and 2019 was 65.5%. The BCG vaccine coverage was 53.5% in 2000, 56.9% in 2005, 64.4% in 2011, 79.6% in 2016, and 79.0% in 2019. BCG vaccination coverage increased by 47.6% in Ethiopia from 2000 to 2019, but substantial geographical inequalities in BCG coverage remained at sub-national and local levels. High vaccination coverage was observed in northern, western, and central parts of Ethiopia. Climatic and demographic factors such as temperature, altitude, and population density were positively associated with BCG vaccination coverage. Whereas, healthcare access factors such as distance to health facilities and travel time to the nearest cities were negatively associated with BCG vaccine coverage in Ethiopia. Conclusion: Despite substantial progress in national BCG vaccination coverage, marked spatial variation in BCG coverage persists throughout the country at sub-national and local levels. Healthcare access and climatic and demographic factors determined the spatial distribution of BCG vaccination coverage. Maintaining a high level of vaccination coverage across geographical areas is important to prevent TB in Ethiopia.